wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38654762-236FB036-6CB5-4B8A-B058-FCEEDDAB0C0A
Q38654762-236FB036-6CB5-4B8A-B058-FCEEDDAB0C0A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38654762-236FB036-6CB5-4B8A-B058-FCEEDDAB0C0A
SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials.
P2860
Q38654762-236FB036-6CB5-4B8A-B058-FCEEDDAB0C0A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38654762-236FB036-6CB5-4B8A-B058-FCEEDDAB0C0A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e3b2385e4023fb8516575dcf1eff48be443d0f97
P2860
Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomised, double-blind, placebo-controlled, phase 3 trial.